Could a Paper-Based Diagnostic Deliver Rapid, Point-of-Care Test Results?

The developer seeks to introduce a low-cost, point-of-care test that could deliver quick results with the help of a smartphone app.

Image courtesy of Group K Diagnostics

Group K Diagnostics has taken the “Best of the Best” spot at Mid-Atlantic Bio Angels’s (MABA) 1st Pitch Life Science event in December. The company is developing the MultiDiagnostic, a low-cost, point-of-care test using paper-based microfluidics. About 20 minutes or so after adding a test sample to the card, users would take a picture and upload it to a smartphone app or use a printed visual comparison chart to read the results, the company reports on its Web site.

An initial diagnostic system would test liver function, and twelve more tests are in production, with over 60 in the pipeline, it was reported in a news release on the 1st Pitch award.

“As you can see from the picture [above], we can increase the amount of tests run by adding additional cards up to 10 cards,” Brianna Wronko, CEO/Founder of Group K, told MD+DI. “There are three tests on each card. The picture shows two cards (6 tests). It is modular in that the procedure for testing is the same no matter the test.”

Wronko explained to MD+DI that Group K is in the IRB process for a patient trial at PennMed, “and we will submit a 510(k) and CLIA in April of this coming year.”

“We are gratified to have been chosen among such an impressive field of companies to be the ‘Best of the Best’ at 1st Pitch this year,” she stated in the release. “We believe our rapid, cost-effective diagnostics will present a true advantage in the market and to patient care, and we appreciate the support we’ve received from MABA in terms of feedback and attention as we continue to develop our platform.”

“Over the course of this year, we saw a variety of strong companies at our 1st Pitch events. Six 2017 “Best in Show” winners, packing new and improved pitches, came to the Alexandria Center to compete for the title of “Best of the Best”. We are pleased that the audience selected Group K, which delivered an excellent presentation, as ‘Best of the Best,’” stated Yaniv Sneor, a MABA co-founder and president of Blue Cactus Consulting, in the statement. “We look forward to seeing Group K continue its development and bring its technology to market.”

For more details on the 1st Pitch program, click here.

Wronko had published a pitch in January 2017 on YouTube.

*****************************

Developing your own medical device? MD&M West has several conferences and on-floor sessions to help you further your education. Here are just a couple:
 

Tuesday, February 6 | 10:15am - 11:00am

"Flexible, Organic & Biodegradable: Stanford Researchers Develop New Wave of Electronics"

Speaker: Levent Beker (Stanford University) 

Pass Type: Conference (Paid)

 

Tuesday, February 6 | 1:15pm - 2:00pm

"Shaking Hands with the Future: Synthetic Touch in Bionics"

Speaker: Jeremy Fishel (SynTouch Inc)

Free Content & Activities: Center Stage

Daphne Allen

Daphne Allen is a contributor to MD+DI and currently serves as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered pharmaceutical and medical device packaging, labeling, manufacturing, and regulatory issues for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.

 

Filed Under
500 characters remaining